ERBB2 and breast carcinoma: The meta-analysis showed that the HER2 codon 655 Val allele was significantly associated with an increased risk of breast cancer in an allele genetic model (additive model, OR 1.21, 95% CI 1.07-1.36; I2=61.0%; n=16).